Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 5 , Pages 336-342 , September 2009

Preconditioning with Sublethal Ischemia or Intermittent Normobaric Hyperoxia Up-regulates Glutamate Transporters and Tumor Necrosis Factor-α Converting Enzyme in the Rat Brain

  • Mohammad Reza Bigdeli, PhD

      Affiliations

    • Faculty of Biological Sciences, Shahid Beheshti University, G.C., Tehran, Iran
    • Corresponding Author InformationAddress correspondence to Mohammad Reza Bigdeli, PhD, Faculty of Biological Sciences, Shahid Beheshti University, G.C., Tehran, Iran.
  • ,
  • Mehdi Rahnema, PhD

      Affiliations

    • Department of Biology, Islamic Azad University-Zanjan Branch, Zanjan, Iran
  • ,
  • Ali Khoshbaten, PhD

      Affiliations

    • Research Center for Chemical Injuries, Baqiyatallah Medical Sciences University, Tehran, Iran

Received 5 October 2008 ,Revised 26 November 2008 ,Accepted 16 December 2008.

References 

  1. Aoyama K, Suh SW, Hamby AM, et al. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat Neurosci. 2006;9(1):119–126
  2. Bigdeli MR, Hajizadeh S, Froozandeh M, et al. Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue. Brain Res. 2007;1152:228–233
  3. Bigdeli MR, Khoshbaten A. In vivo preconditioning with normobaric hyperoxia induces ischemic tolerance partly by triggering tumor necrosis factor-alpha converting enzyme/tumor necrosis factor-alpha/nuclear factor-kappaB. Neuroscience. 2008;153:671–678
  4. Bigdeli MR, Hajizadeh S, Froozandeh M, et al. Normobaric hyperoxia induces ischemic tolerance and upregulation of glutamate transporters in the rat brain and serum TNF-α level. Exp Neurol. 2008;212:298–306
  5. Chen SH, Cheung RT. Peripheral and central administration of neuropeptide Y in a rat middle cerebral artery occlusion stroke model reduces cerebral blood flow and increases infarct volume. Brain Res. 2002;9:138–143
  6. Gidday JM, Fitzgibbons JC, Shah AR, et al. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett. 1994;168:221–224
  7. Gill DJ, Low BC, Grigor MR. Interleukin-1 beta and tumor necrosis factor-alpha stimulate the cat-2 gene of the L-arginine transport in cultured vascular smooth muscle cells. J Biol Chem. 1996;271:11280–11283
  8. Gonzalez-Zulueta M, Feldman AB, Klesse LJ, et al. Requirement for nitric oxide activation of p21 (ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci U S A. 2000;97:436–441
  9. Helms A, Whelan H, Torbey M. Hyperbaric oxygen therapy of cerebral ischemia. Cerebrovasc Dis. 2005;20:417–426
  10. Hurtado O, Cárdenas A, Lizasoain I, et al. Up-regulation of TNF-a convertase (TACE/ADAM17) after oxygen-glucose deprivation in rat forebrain slices. Neuropharmacology. 2001;40:1094–1102
  11. Hurtado O, Lizasoain I, Fernández-Tomé P, et al. TACE/ADAM17-TNF-a pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate. J Cereb Blood Flow Metab. 2002;22:576–585
  12. Kitagawa K, Matsumoto M, Tagaya M, et al. Ischemic tolerance phenomenon found in the brain. Brain Res. 1990;528:21–24
  13. Liu J, Ginis I, Spatz M, et al. Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-α and ceramide. Am J Physiol Cell Physiol. 2000;278:C144–C153
  14. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84–91
  15. Mattson MP, Culmsee C, Yu Z, et al. Roles of nuclear factor kappa B in neuronal survival and plasticity. J Neurochem. 2000;74:443–456
  16. McLaughlin BA, Hartnett KA, Erhardt KA, et al. Caspase 3 activation is essential for neuroprotection in preconditioning. Proc Natl Acad Sci U S A. 2003;100:715–720
  17. Mochizuki T, Satsu H, Shimizu M. Tumor necrosis factor alpha stimulates taurine uptake and transporter gene expression in human intestinal Caco-2 cells. FEBS Lett. 2002;517:92–96
  18. Namura S, Maeno H, Takami S, et al. Inhibition of glial glutamate transporter GLT-1 augments brain edema after transient focal cerebral ischemia in mice. Neurosci Lett. 2002;324:117–120
  19. Ohtsuki T, Ruetzler C, Tasaki K, et al. Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. J Cereb Blood Flow Metab. 1996;16:1137–1142
  20. Ohtsuki T, Matsumoto M, Kuwabara K, et al. Influence of oxidative stress on induced tolerance to ischemia in gerbil hippocampal neurons. Brain Res. 1992;599:246–252
  21. Perez-Pinzon MA, Mumford PL, Rosenthal M, et al. Anoxic preconditioning in hippocampal slices: Role of adenosine. Neuroscience. 1996;75:687–694
  22. Pradillo J, Hurtado O, Romera C, et al. TNF-R1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning. Neuroscience. 2006;138:1171–1178
  23. Ravati A, Ahlemeyer B, Becker A, et al. Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor-κB. J Neurochem. 2001;78:909–919
  24. Riepe MW, Esclaire F, Kasischke K, et al. Increased hypoxic tolerance by chemical inhibition of oxidative phosphorylation: “Chemical preconditioning. J Cereb Blood Flow Metab. 1997;17:257–264
  25. Romera C, Hurtado O, Botella S, et al. In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17–tumor necrosis factor-α pathway. J Neurosci. 2004;24(6):1350–1357
  26. Ruscher K, Freyer D, Karsch M, et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: Evidence from an in vitro model. J Neurosci. 2002;22:10291–10301
  27. Shimazaki K, Ishida A, Kawai N. Increase in bcl-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus. Neurosci Res. 1994;20:95–99
  28. Swanson RA, Morton MT, Tsao-Wu G, et al. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 1990;10(2):290–293
  29. Tanaka K. Functions of glutamate transporters in the brain. Neurosci Res. 2000;37:15–19
  30. Toyoda T, Kassell NF, Lee KS. Induction of ischemic tolerance and antioxidant activity by brief focal ischemia. Neuroreport. 1997;8:847–851
  31. Trendelenburg G, Prass K, Priller J, et al. Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia. J Neurosci. 2002;22:5879–5888
  32. Wada K, Kiyazawa T, Nomura N, et al. Mn-SOD and Bcl-2 expression after repeated hyperbaric oxygenation. Acta Neurochir Suppl. 2000;76:285–290
  33. Wick A, Wick W, Waltenberger W, et al. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci. 2002;22:6401–6407
  34. Yamashita A, Makita K, Kuroiwa T, et al. Glutamate transporters GLAST and EAAT4 regulate postischemic Purkinje cell death: An in vivo study using a cardiac arrest model in mice lacking GLAST or EAAT4. Neurosci Res. 2006;55:264–270

PII: S1052-3057(08)00279-6

doi: 10.1016/j.jstrokecerebrovasdis.2008.12.005

Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 5 , Pages 336-342 , September 2009